Callan JMB Receives Request from the State of Texas Department of Health and Human Services to be on Standby in Response to Measles Outbreak
Callan JMB received a 5-year contingency contract in 2023 from the State of Texas to receive, store and distribute medical countermeasures as requested by DSHS
SPRING BRANCH, Texas, March 03, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services, today announced it has received a request from the State of Texas Department of Health and Human Services to be on standby in readiness to assist with the response to the recent outbreak of measles.
The State of Texas awarded Callan JMB a five-year contingency contract in 2023 to receive, store, and distribute medical countermeasures as requested by the Department of State Health Services (DSHS) for public health emergencies. The current measles outbreak has already taken one life, and the State of Texas is responding to the emergency. Callan JMB is proactively submitting to DSHS a 30-day roster of personnel available 24/7 to handle any receipt and distribution requests immediately.
“Rapid response to public health emergencies is the heartbeat of Callan JMB,” states Wayne Williams, CEO of Callan JMB. “Our primary concern is the welfare of communities, which is why we are always prepared with expert staff, fully equipped facilities, and a top-level quality-controlled inventory management system.”
Callan JMB was awarded its first emergency response contingency contract by the State of Texas in 2018. That contract was activated in 2020 to respond to the COVID-19 and MPOX pandemic. Over the course of the pandemic Callan JMB provided storage and pin-point distribution of over 2 million COVID-19 and MPOX vaccines and therapeutics rapidly and effectively, as well as qualified strike teams to administer vaccines whenever needed. After the COVID and MPOX emergencies were declared over, Callan JMB was awarded its second emergency contingency contract. Using the procedures that were successful in the pandemic, Callan JMB stands ready to mitigate the effects of this new measles outbreak to protect the residents of Texas.
About Callan JMB
Callan JMB is an integrative logistics company empowering the healthcare industry and emergency management agencies through exceptional fulfillment, storage, monitoring, and cold chain logistics services to secure medical materials and protect patients and communities with compliant, safe, and effective medicines. The combined expertise of our CEO, COO and CIO in supply chain logistics, thermodynamics, biologics, inventory management, regulatory compliance and emergency preparedness is unparalleled in the industry. We offer the Gold Standard in client experience with customizable interfaces, next-level reliability in shipping and environmental sustainability in our reusable thermal shippers.
Forward-Looking Statement
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (which Sections were adopted as part of the Private Securities Litigation Reform Act of 1995). Statements preceded by, followed by or that otherwise include the words “believe,” “anticipate,” “estimate,” “expect,” “intend,” “plan,” “project,” “prospects,” “outlook,” and similar words or expressions, or future or conditional verbs, such as “will,” “should,” “would,” “may,” and “could,” are generally forward-looking in nature and not historical facts. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company 's actual results, performance, or achievements to be materially different from any anticipated results, performance, or achievements for many reasons. The Company disclaims any intention to, and undertakes no obligation to, revise any forward-looking statements, whether as a result of new information, a future event, or otherwise. For additional risks and uncertainties that could impact the Company 's forward-looking statements, please see the Company 's Registration Statement Under the Securities Act of 1933 on Form S-1, including but not limited to the discussion under “Risk Factors” therein, which the Company filed with the SEC and which may be viewed at http://www.sec.gov/.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
212.896.1254
© 2025 GlobeNewswire, Inc. All Rights Reserved.
